APA (7th ed.) Citation

P, R., B, P., E, A., T, L. V., D, K., D, B., . . . P, T. (2026). BCG immunotherapy for bladder cancer triggers systemic and local BCG-specific CD4+ Th1 responses. IScience, 29(2), 114676. https://doi.org/10.1016/j.isci.2026.114676

Chicago Style (17th ed.) Citation

P, Rollin, et al. "BCG Immunotherapy for Bladder Cancer Triggers Systemic and Local BCG-specific CD4+ Th1 Responses." IScience 29, no. 2 (2026): 114676. https://doi.org/10.1016/j.isci.2026.114676.

MLA (9th ed.) Citation

P, Rollin, et al. "BCG Immunotherapy for Bladder Cancer Triggers Systemic and Local BCG-specific CD4+ Th1 Responses." IScience, vol. 29, no. 2, 2026, p. 114676, https://doi.org/10.1016/j.isci.2026.114676.